Portfolio, Press Eclipsebio Expands Intellectual Property Portfolio to Support New Product Suites Designed to Probe RNA Structure and Reveal Ribosome Occupancy and RNA… Posted on October 5, 2022 by iGlobe Partners Orbital Therapeutics Acquired by Bristol-Myers
